Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Hicks

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 27, 2014
A new rabbit monoclonal E-cadherin antibody [EP700Y] shows higher sensitivity than mouse monoclonal E-cadherin [HECD-1] antibody in breast ductal carcinomas and does not stain breast lobular carcinomasLaura L Hoang, Ping Tang, David G Hicks, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 8, 2009
Malignant solitary fibrous tumor: report of 3 cases with unusual featuresYingchuan Hu, Tara J Mahar, David G Hicks, et al.
Human Pathology|April 29, 2026
Comparison of the Somatic Mutations in Breast Carcinomas in Sporadic and BRCA1 Carrier Patients through Targeted Next Generation SequencingCynthia Reyes Barron, Madhurya Ramineni, Brian S Finkelman, et al.
Seminars in Diagnostic Pathology|July 25, 2022
HER2-low breast cancers: Current insights and future directionsHuina Zhang, Cansu Karakas, Haley Tyburski, et al.
International Journal of Fertility and Women'S Medicine|February 3, 2007
HER2 status in bilateral breast cancerJoseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
American Journal of Clinical Pathology|January 25, 2021
Significance of HER2 in Microinvasive Breast CarcinomaHuina Zhang, Ioana Moisini, Bradley M Turner, et al.
Human Pathology|April 26, 2017
p53 alteration in morphologically normal/benign breast luminal cells in BRCA carriers with or without history of breast cancerXi Wang, Amber A El-Halaby, Hengwei Zhang, et al.
BMC Clinical Pathology|December 15, 2015
Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patientsXi Wang, Brian Z Ring, Robert S Seitz, et al.
American Journal of Clinical Pathology|January 10, 2019
Impact of Specimen Type and Specimen Number on HER2 Status in Gastroesophageal Junction and Gastric AdenocarcinomaAaron R Huber, Brandon Buscaglia, Brooke R Koltz, et al.
Annals of Surgical Oncology|October 19, 2011
Predictors of nipple-areolar complex involvement by breast carcinoma: histopathologic analysis of 787 consecutive therapeutic mastectomy specimensJianli Wang, Xiuli Xiao, Jianmin Wang, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 27, 2014
A new rabbit monoclonal E-cadherin antibody [EP700Y] shows higher sensitivity than mouse monoclonal E-cadherin [HECD-1] antibody in breast ductal carcinomas and does not stain breast lobular carcinomasLaura L Hoang, Ping Tang, David G Hicks, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 8, 2009
Malignant solitary fibrous tumor: report of 3 cases with unusual featuresYingchuan Hu, Tara J Mahar, David G Hicks, et al.
Human Pathology|April 29, 2026
Comparison of the Somatic Mutations in Breast Carcinomas in Sporadic and BRCA1 Carrier Patients through Targeted Next Generation SequencingCynthia Reyes Barron, Madhurya Ramineni, Brian S Finkelman, et al.
Seminars in Diagnostic Pathology|July 25, 2022
HER2-low breast cancers: Current insights and future directionsHuina Zhang, Cansu Karakas, Haley Tyburski, et al.
International Journal of Fertility and Women'S Medicine|February 3, 2007
HER2 status in bilateral breast cancerJoseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
American Journal of Clinical Pathology|January 25, 2021
Significance of HER2 in Microinvasive Breast CarcinomaHuina Zhang, Ioana Moisini, Bradley M Turner, et al.
Human Pathology|April 26, 2017
p53 alteration in morphologically normal/benign breast luminal cells in BRCA carriers with or without history of breast cancerXi Wang, Amber A El-Halaby, Hengwei Zhang, et al.
BMC Clinical Pathology|December 15, 2015
Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patientsXi Wang, Brian Z Ring, Robert S Seitz, et al.
American Journal of Clinical Pathology|January 10, 2019
Impact of Specimen Type and Specimen Number on HER2 Status in Gastroesophageal Junction and Gastric AdenocarcinomaAaron R Huber, Brandon Buscaglia, Brooke R Koltz, et al.
Annals of Surgical Oncology|October 19, 2011
Predictors of nipple-areolar complex involvement by breast carcinoma: histopathologic analysis of 787 consecutive therapeutic mastectomy specimensJianli Wang, Xiuli Xiao, Jianmin Wang, et al.
Pageof 14